PRICE T ROWE ASSOCIATES INC 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
PRICE T ROWE ASSOCIATES INC | 2,492,213 4.700% |
-30,491 (-1.21%) |
Filing |
| 2024-02-14 10:02 am Purchase |
2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
PRICE T ROWE ASSOCIATES INC | 2,522,704 5.600% |
2,522,704 (New Position) |
Filing |